This method for embryo selection reduces the number of transfers needed to have a healthy baby, and it also significantly decreases the likelihood of miscarrying.
It is a well-known fact that maternal age plays a role in reproduction. We are all aware that between the ages of 25 and 35 female reproductive capacity declines by up to 50%. After this age, a female may have difficulty conceiving or may be more likely to spontaneously miscarry. The good news is that science is progressing in terms of prevention: reproductive medicine offers us a solution thanks to the information we obtain from the DNA of our embryos through Pre-Implantation Genetic Diagnosis (PGD).
When this type of technique is used in assisted reproduction, it is possible to genetically analyse embryos to determine which ones are carriers of chromosome abnormalities or monogenic disorders. In a Pre‑Implantation Genetic Diagnosis (PGD), the embryos are studied in order to transfer those which are unaffected and to ensure that the baby will be free of the condition being studied.
In this regard, we study the DNA of the embryos and select those which are free of chromosome abnormalities. This allows us to increase the likelihood of pregnancy and, at the same time, decrease the likelihood of implantation failure, spontaneous miscarriage and/or therapeutic abortion. Read more ›